NMPA Approval

Olmesartan Medoxomil Orally Disintegrating Tablets

Approval Number

国药准字H20244148

Company广州一品红制药有限公司

Registration Date

June 25, 2024

Drug Information

Generic Name

奥美沙坦酯口崩片

Dosage Form

片剂

Strength

20mg

Drug Type

化学药品

Registration Date

June 25, 2024

Company Information

Applicant Company

Company Name广州一品红制药有限公司

Company Address

广州市经济技术开发区东区东博路6号

Manufacturing Company

Company Name广州一品红制药有限公司

Company Address

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯口崩片 - NMPA 批准文号 | MedPath